| __timestamp | Johnson & Johnson | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 152500000 |
| Thursday, January 1, 2015 | 9046000000 | 187800000 |
| Friday, January 1, 2016 | 9095000000 | 184000000 |
| Sunday, January 1, 2017 | 10554000000 | 167700000 |
| Monday, January 1, 2018 | 10775000000 | 218600000 |
| Tuesday, January 1, 2019 | 11355000000 | 187400000 |
| Wednesday, January 1, 2020 | 12340000000 | 177700000 |
| Friday, January 1, 2021 | 14277000000 | 122000000 |
| Saturday, January 1, 2022 | 14135000000 | 123100000 |
| Sunday, January 1, 2023 | 15048000000 | 122500000 |
| Monday, January 1, 2024 | 17232000000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, innovation is key. Johnson & Johnson and Perrigo Company plc, two giants in the field, have shown contrasting approaches to research and development (R&D) investments over the past decade. From 2014 to 2023, Johnson & Johnson consistently outpaced Perrigo in R&D spending, with an average annual investment of approximately $11.5 billion, compared to Perrigo's $164 million. This represents a staggering 7,000% higher investment by Johnson & Johnson, underscoring their commitment to innovation. Notably, Johnson & Johnson's R&D expenses grew by 77% over this period, peaking at $15 billion in 2023. In contrast, Perrigo's investment remained relatively stable, with a slight decline in recent years. This disparity highlights Johnson & Johnson's strategic focus on pioneering advancements, while Perrigo maintains a more conservative approach.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending